Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelinationAmin Zarghami, Ingrid van der Mei, Mohammad Akhtar Hussain, et al.Therapeutic Advances in Neurological Disorders|March 25, 2024
Comparative efficacy of ofatumumab <i>versus</i> oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisonsNicholas Riley, Christopher Drudge, Morag Nelson, et al.Multiple Sclerosis and Related Disorders|November 11, 2019
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic reviewWolfgang Marx, Meghan Hockey, Amelia J McGuinness, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonGrant P Parnell, Prudence N Gatt, Fiona C McKay, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationSudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studiesBart Van Wijmeersch, Barry A Singer, Aaron Boster, et al.Human Molecular Genetics|March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesisKaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.The Journal of Applied Laboratory Medicine|October 31, 2021
Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical DiagnosticsJoseph A Lopez, Samuel D Houston, Fiona Tea, et al.Brain : a Journal of Neurology|December 12, 2023
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndromeHelmut Butzkueven, Anne-Louise Ponsonby, Mark S Stein, et al.Acta Neuropathologica Communications|September 5, 2019
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelinationFiona Tea, Joseph A Lopez, Sudarshini Ramanathan, et al.Pageof 4